SYMPLICITY™ BLOOD PRESSURE PROCEDURE
A complementary treatment for high blood pressure
Think beyond the typical treatments for hypertension.
Interested in lowering your blood pressure? The Medtronic Symplicity™ blood pressure procedure goes beyond — beyond lifestyle changes, beyond medications.
Understand your high blood pressure.
High blood pressure, a very common health issue around the world, often has no symptoms but raises the risk of heart attacks, strokes, heart failure, and kidney failure.1
~46%
of adults with high blood pressure are unaware they have it.1
~80%
of people with high blood pressure do not have it under control.1
> 1 billion
adults are affected worldwide.1
Beyond a doubt.
The Symplicity blood pressure procedure is a minimally invasive procedure that is proven to be safe and effective.2,3
Live beyond the risks of high blood pressure.
Find out how successful the Symplicity blood pressure procedure has been, from clinical studies to real-world patients and their stories.
“I'm seeing a reduction in my blood pressure.”
– Paul, patient with high blood pressure who received the Symplicity blood pressure procedure.
Not every person will experience the same results. The Medtronic Symplicity blood pressure procedure does have known risks. These risks should be considered in relation to the potential benefits of the procedure.
Find a Symplicity specialist.
Here’s how you can find a doctor near you who is experienced in the Symplicity blood pressure procedure.
Is the Symplicity blood pressure procedure right for you?
Answer a few simple questions and talk to your doctor to see if the procedure may be right for you.
References
1
Hypertension Fact Sheet. World Health Organization. Available at: who.int/news-room/fact-sheets/detail/hypertension. Accessed August 28, 2023.
2
Kandzari DE, Townsend RR, Kario K, et al. Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications. J Am Coll Cardiol. November 7, 2023;82(19):1809–1823.
3
Böhm M, Kario K, Kandzari DE, et al. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomized, sham-controlled trial. Lancet. May 2, 2020;395(10234):1444–1451.